title: Efficacy and safety of liver-specific MRI contrast agents in rats with hepatitis and cirrhosis.
authors.affiliation: Research Department, Nihon Schering K.K., Osaka, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Kato
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Ihara
authors.forename: T
authors.initials: T
authors.lastname: Tsujimoto
authors.forename: T
authors.initials: T
authors.lastname: Miyazawa
mesh_terms: D000818:Animals; D003287:Contrast Media; D003911:Dextrans; D004195:Disease Models, Animal; D005260:Female; D052203:Ferrosoferric Oxide; D019786:Gadolinium DTPA; D006505:Hepatitis / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D007501:Iron; D008106:Liver Cirrhosis, Experimental / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D009942:Organometallic Compounds; D010087:Oxides; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D009942:Organometallic Compounds; D010087:Oxides; C073590:gadolinium ethoxybenzyl DTPA; D007501:Iron; C065507:ferumoxides; D019786:Gadolinium DTPA; D052203:Ferrosoferric Oxide